Atlas Trials

Randomized, Double Blind, Efficacy Study of Escitalopram in ENT Cancer Patients Suffering From Emotional Distress

Clinical trial NCT02246244 · COMPLETED

Trial details

NCT number
NCT02246244
Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
ENT Cancer
Start date
2009-04-01
Primary completion
2013-03-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.